Pivot Medical, Inc, a device company focusing on hip arthroscopy, has named Kevin Sidow to the company’s Board of Directors. Sidow, who is president and CEO of Moximed, Inc, has worked for more than 20 years in the orthopedic medical device market.
Sidow Joins Pivot Medical Board
1 min read Premium comments
Prior to running Moximed, he was president and CEO of St. Francis Medical Technologies, Inc. a firm that developed treatments for degenerative spinal disorders. Kyphon purchased St. Francis Medical for $725 million in January 2007. Before joining St. Francis Medical, Sidow was the Worldwide President of DePuy, Inc. where he oversaw the global orthopedic, spine, trauma and sports medicine business.
“We are delighted to attract someone with Kevin’s experience and expertise in orthopedics to join the board of Pivot Medical. His insights will contribute substantially to Pivot’s commercial growth, ” said John J. Savarese, M.D., Chairman of Pivot. Other members serving on the Pivot Medical board are, Jack Giroux, Julian Nikolchev, John J. Savarese, Michael Lynn, John F. Maroney, and Guy L. Mayer.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.